$IMUX

$8.15 +$0.54 (7.03%) Live

$IMUX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 13.6M shares outstanding

Who owns IMUX?

By type of holder

Institutions 61.6% Insiders 0.7% Everyone else 37.7%

Concentration Top 10 holders own 468.4%

BVF Partners L P/il 99.9% · Lampert Mark N 99.9%

Institutional ownership

61.6%

-38.4 pts vs last qtr

Institutional holders

-23 vs last qtr

Net shares bought

−57.2M

by institutions in Q2 2026

New / sold out

11 / 34

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Braidwell LP NEW +645.0K
Jones Hill Capital LP NEW +539.8K

Biggest sellers in Q2 2026

Aberdeen Group plc −7.4M
BVF Inc/il −6.9M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Immunic, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+893.9%

+58.30% a year

Each share's claim on the business

−89.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $41.1M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years15% 3–5 years0% 1–3 years47% Under 1 year38%

Quarterly turnover

45.6%

of institutional shares changed hands

Top 10 managers, median time held

1.3 years

Super Investors

Investment managers reporting IMUX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AG Aberdeen Group plc	824.4K	6.04%	−7.4M (−90.0%)	2025	0.0%
Shares held by quarter Peak holding8.2M (Q2'25) Change over 8 quarters+824.4K Share of the company6.040% Aberdeen Group plc's full portfolio →
BI BVF Inc/il 13D · 10.0%	765.3K	5.61%	−6.9M (−90.0%)	2024	0.3%
Shares held by quarter Peak holding8.9M (Q3'24) Change over 8 quarters−8.1M Share of the company5.610% Disclosed stake13D · 10.0% BVF Inc/il's full portfolio →

Aberdeen Group plc

824.4K

% of company

6.04%

Change vs last qtr

−7.4M (−90.0%)

Held since

2025

BVF Inc/il

13D · 10.0%

765.3K

% of company

5.61%

Change vs last qtr

−6.9M (−90.0%)

Held since

2024

28 more super investors behind a free account

See every manager holding Immunic, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IMUX on Form N-PORT; together they hold 11.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AH abrdn Healthcare Investors abrdn Healthcare Investors	$7.28M	473.9K	3.47%	0.53%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$6.13M	399.1K	2.92%	0.00%	June 30, 2026

abrdn Healthcare Investors

Position value

$7.28M

% of company

3.47%

% of the fund

0.53%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$6.13M

% of company

2.92%

% of the fund

0.00%

As of

June 30, 2026

21 more funds behind a free account

See every fund holding Immunic, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BP BVF Partners L P/il 5%+ holder 13D · 10.0%	13.6M	99.90%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company99.900% Disclosed stake13D · 10.0% View the 13D/G filing →
LM Lampert Mark N 5%+ holder 13D · 10.0%	13.6M	99.90%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company99.900% Disclosed stake13D · 10.0% View the 13D/G filing →

BVF Partners L P/il

5%+ holder13D · 10.0%

13.6M

% of company

99.90%

Change vs last qtr

—

Held since

—

Lampert Mark N

5%+ holder13D · 10.0%

13.6M

% of company

99.90%

Change vs last qtr

—

Held since

—

13 more holders behind a free account

See every insider and 5%+ holder of Immunic, Inc..

Comments